Edwards Lifesciences Corporation Excess Tax Benefit from Share-based Compensation, Financing Activities
Edwards Lifesciences Corporation (EW) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-02-15
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2018 was $0.00.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $64.30M, a 55.69% increase from fiscal 2015.
- Edwards Lifesciences Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $41.30M, a 16.40% decline from fiscal 2014.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-15 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $0.00 derived: sum of 2 quarters · filed 2019-02-15 | $0.00 derived: sum of 3 quarters · filed 2019-02-15 | $0.00 10-K · filed 2019-02-15 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $0.00 derived: sum of 2 quarters · filed 2017-10-27 | $0.00 10-Q · filed 2017-10-27 | $7.70M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $0.00 10-Q · filed 2017-07-28 | $7.70M derived: sum of 3 quarters · filed 2019-02-15 | $27.10M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-04-28 | $7.70M derived: sum of 2 quarters · filed 2019-02-15 | $27.10M derived: sum of 3 quarters · filed 2019-02-15 | $53.20M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2016-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $27.10M derived: sum of 2 quarters · filed 2019-02-15 | $53.20M derived: sum of 3 quarters · filed 2019-02-15 | $64.30M 10-K · filed 2019-02-15 | ||
| 2016-09-30 | $19.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $45.50M derived: sum of 2 quarters · filed 2017-10-27 | $56.60M 10-Q · filed 2017-10-27 | $70.80M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $26.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $37.20M 10-Q · filed 2017-07-28 | $51.40M derived: sum of 3 quarters · filed 2018-02-16 | $58.80M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $11.10M 10-Q · filed 2017-04-28 | $25.30M derived: sum of 2 quarters · filed 2018-02-16 | $32.70M derived: sum of 3 quarters · filed 2018-02-16 | $42.60M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2015-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $21.60M derived: sum of 2 quarters · filed 2018-02-16 | $31.50M derived: sum of 3 quarters · filed 2018-02-16 | $41.30M 10-K · filed 2018-02-16 | ||
| 2015-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $17.30M derived: sum of 2 quarters · filed 2016-10-28 | $27.10M 10-Q · filed 2016-10-28 | $42.30M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-06-30 | $9.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $19.70M 10-Q · filed 2016-07-29 | $34.90M derived: sum of 3 quarters · filed 2017-02-17 | $47.80M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-03-31 | $9.80M 10-Q · filed 2016-04-29 | $25.00M derived: sum of 2 quarters · filed 2017-02-17 | $37.90M derived: sum of 3 quarters · filed 2017-02-17 | $45.20M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2014-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $28.10M derived: sum of 2 quarters · filed 2017-02-17 | $35.40M derived: sum of 3 quarters · filed 2017-02-17 | $49.40M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $12.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $20.20M derived: sum of 2 quarters · filed 2015-10-29 | $34.20M 10-Q · filed 2015-10-29 | $44.40M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $21.30M 10-Q · filed 2015-07-29 | $31.50M derived: sum of 3 quarters · filed 2016-02-19 | $35.90M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-03-31 | $14.00M 10-Q · filed 2015-04-29 | $24.20M derived: sum of 2 quarters · filed 2016-02-19 | $28.60M derived: sum of 3 quarters · filed 2016-02-19 | $25.90M derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2013-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $14.60M derived: sum of 2 quarters · filed 2016-02-19 | $11.90M derived: sum of 3 quarters · filed 2016-02-19 | $73.50M 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $1.70M derived: sum of 2 quarters · filed 2014-10-31 | $63.30M 10-Q · filed 2014-10-31 | $80.80M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2013-06-30 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $58.90M 10-Q · filed 2014-08-04 | $76.40M derived: sum of 3 quarters · filed 2015-02-20 | $72.40M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2013-03-31 | $61.60M 10-Q · filed 2014-05-02 | $79.10M derived: sum of 2 quarters · filed 2015-02-20 | $75.10M derived: sum of 3 quarters · filed 2015-02-20 | $79.90M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2012-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $13.50M derived: sum of 2 quarters · filed 2015-02-20 | $18.30M derived: sum of 3 quarters · filed 2015-02-20 | $56.50M 10-K · filed 2015-02-20 | ||
| 2012-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $800.00K derived: sum of 2 quarters · filed 2013-11-07 | $39.00M 10-Q · filed 2013-11-07 | $41.40M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $43.00M 10-Q · filed 2013-08-06 | $45.40M derived: sum of 3 quarters · filed 2014-02-28 | $37.80M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $38.20M 10-Q · filed 2013-05-06 | $40.60M derived: sum of 2 quarters · filed 2014-02-28 | $33.00M derived: sum of 3 quarters · filed 2014-02-28 | $29.00M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2011-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$5.20M derived: sum of 2 quarters · filed 2014-02-28 | -$9.20M derived: sum of 3 quarters · filed 2014-02-28 | $6.00M 10-K · filed 2014-02-28 | ||
| 2011-09-30 | -$7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$11.60M derived: sum of 2 quarters · filed 2012-11-07 | $3.60M 10-Q · filed 2012-11-07 | $47.00M 10-Q · filed 2011-11-08 | $16.70M derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $11.20M 10-Q · filed 2012-08-07 | $36.40M 10-Q · filed 2011-08-08 | $24.30M derived: sum of 3 quarters · filed 2013-02-28 | $34.80M derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-03-31 | $15.20M 10-Q · filed 2012-05-09 | $28.30M derived: sum of 2 quarters · filed 2013-02-28 | $38.80M derived: sum of 3 quarters · filed 2013-02-28 | $51.10M derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2010-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $23.60M derived: sum of 2 quarters · filed 2013-02-28 | $35.90M derived: sum of 3 quarters · filed 2013-02-28 | $55.10M 10-K · filed 2013-02-28 | ||
| 2010-09-30 | $10.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $22.80M derived: sum of 2 quarters · filed 2011-11-08 | $42.00M 10-Q · filed 2011-11-08 | $49.70M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-30 | $12.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $31.50M 10-Q · filed 2011-08-08 | $39.20M derived: sum of 3 quarters · filed 2012-02-27 | $41.80M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-31 | $19.20M 10-Q · filed 2011-05-09 | $26.90M derived: sum of 2 quarters · filed 2012-02-27 | $29.50M derived: sum of 3 quarters · filed 2012-02-27 | |||
| 2009-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $10.30M derived: sum of 2 quarters · filed 2012-02-27 | $20.60M 10-K · filed 2012-02-27 | |||
| 2009-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $12.90M 10-Q · filed 2010-11-08 | ||||
| 2009-06-30 | $10.30M 10-Q · filed 2010-08-06 | |||||
| 2008-12-31 | $14.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |